Xenon Pharmaceuticals Inc XENE
$62.67
▼ -2.37%
($-1.52)
🗓️ Earnings Next Week
Open
$63.94
Prev Close
$64.19
Day Range
$62.56 – $64.51
52W Range
$30.00 – $72.66
Market Cap
$6.20B
Beta
0.63
EPS (TTM)
$-4.70
📋 Company Profile
| Industry | Biotechnology |
| Country | CA |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-10-17 |
| Shares Out. | 96,670,000 |
| Website | xenon-pharma.com/ ↗ |
| Phone | 16044843300 |
| Employees | 370 |
| Net Income | -$102.3M |
| Free Cash Flow | -$307.3M |
| Total Assets | $1.39B |
| Total Liabilities | $49.0M |
| Equity | $1.34B |
About Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Xenon Pharmaceuticals Inc is a publicly traded company under the ticker symbol XENE on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
26 analysts (2026-07-01)